01 November 1999
Do elevated plasma prothrombin levels correspond to genetic variation in the 3'-untranslated region of the prothrombin gene in type 2 diabetic patients? - preliminary reportMarcin Różalski, Magdalena Boncler, Tadeusz Pietrucha, Cezary Watała
Med Sci Monit 1999; 5(6): BR1065-1069 :: ID: 503097
Background:Numerous coagulation abnormalities resulting in a state of acquired thrombophilia have been demonstrated in the patients suffering from diabetes mellitus. Diabetes itself, however, is known to constitute an additional independent risk factor in the development of vascular complications. Recently, occasional reports pointed to the possible correlation between the genetic polymorphism 20210G/A in 3'-untranslated region in prothrombin gene and the elevated prothrombin level in blood plasma, particularly in the cases of familial thrombophilia. Our aim was to verify the hypothesis whether the elevated plasma prothrombin levels in some patients might correspond to the genetic variation in the 3'-untranslated region of the prothrombin gene in patients with type 2 diabetes mellitus.
Results: We revealed that the averaged plasma level of prothrombin fragment F1+2 in an overall group of 128 type 2 diabetic patients was not significantly different compared to controls (2.93&plusm;2.40 nmol/l vs. 2.21&plusm;1.83 nmol/l); in selected patients (16%), however, the level of F1+2 was vastly increased (7.70&plusm;1.83 nmol/l), although these patients showed no evident clinical symptoms of vascular disease. The frequency of the genetic polymorphism 20210G/A in 3'-untranslated region in prothrombin gene in the examined group of diabetic subjects (1.3%) was not significantly higher compared to the group of control individuals and did not correspond to the increased F1+2 plasma levels: all the diabetic patients with the markedly increased levels of F1+2, were wild type homozygotes 20210G/G.
Conclusions: Overall, we conclude that the genetic polymorphism 20210G/A in 3'-untranslated region in prothrombin gene is not evidently associated with the increased plasma thrombin generation in the examined group of diabetic patients. Other, yet undefined, compounding factors might underlie the accelerated thrombogenesis occurring in some patients with diabetes mellitus.
Keywords: Prothrombin, A20210G prothrombin gene polymorphism, prothrombin fragment F 1+2, Type 2 diabetes mellitus, thrombinogenesis
01 October 2023 : EditorialEditorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution
Med Sci Monit 2023; 29:e942672
02 Oct 2023 : Clinical ResearchComparison of Nanocrystalline Hydroxyapatite Bone Graft with Empty Defects in Long Bone Fractures: A Retros...
Med Sci Monit In Press; DOI: 10.12659/MSM.941112
02 Oct 2023 : Review articleCircadian Rhythms in Cardiovascular Function: Implications for Cardiac Diseases and Therapeutic Opportunities
Med Sci Monit In Press; DOI: 10.12659/MSM.942215
30 Sep 2023 : Clinical ResearchInfluence of Age, Gender, Frailty, and Body Mass Index on Serum IL-17A Levels in Mature Type 2 Diabetic Pat...
Med Sci Monit In Press; DOI: 10.12659/MSM.940128
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
14 Dec 2022 : Clinical ResearchPrevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels
Med Sci Monit 2022; 28:e937990
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292